Seminar, Hosted by NIH Office of Intramural Research
Evolution of the Glutamate Models of Psychosis
Oregon Health & Science University
Abstract
Psychosis is a hallmark of schizophrenia. It typically emerges in late adolescence and is associated with striatal dopamine abnormalities, yet most genes implicated in schizophrenia risk involve ubiquitous targets that do not explain the latent expression of psychosis or the dopaminergic disruptions. This lecture describes an etiologically relevant mechanism for the adolescent onset of dopamine abnormalities and psychosis.
The work focuses on GRIN2A, which encodes the GluN2A subunit of the NMDA receptor; both common variants and rare missense and protein-truncating variants in this gene have been identified as genetic risk factors for schizophrenia. GluN2A levels decline throughout adolescence in midbrain regions containing dopamine neurons, suggesting that variants reducing GRIN2A function could augment this natural developmental process and contribute to the emergence of psychosis at this age. Consistent with this mechanism, virally mediated Grin2a knockout in adolescent rat dopamine neurons produced a phenotype mirroring psychosis, including disrupted salience attribution and dopamine release during prediction-error signalling. The findings give mechanistic insight into how GRIN2A variants may lead to the latent presentation of psychosis and abnormal dopamine dynamics in schizophrenia, and provide a model with construct and face validity for discovering course-altering treatments.